HPV ctDNA Allows for the Detection of Residual Disease in Cervical Cancer

IF 33.3 1区医学 Q1 ONCOLOGY

Cancer discovery Pub Date : 2023-12-08 DOI:10.1158/2159-8290.cd-rw2023-191

引用次数: 0

Abstract

The presence of HPV ctDNA after chemoradiation is predictive of inferior progression-free survival.

查看原文本刊更多论文

HPV ctDNA 可检测宫颈癌残留病灶

放化疗后HPV ctDNA的存在预示着较差的无进展生存期。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer discovery ONCOLOGY-

CiteScore

22.90

自引率

1.40%

发文量

838

审稿时长

6-12 weeks

期刊介绍： Cancer Discovery publishes high-impact, peer-reviewed articles detailing significant advances in both research and clinical trials. Serving as a premier cancer information resource, the journal also features Review Articles, Perspectives, Commentaries, News stories, and Research Watch summaries to keep readers abreast of the latest findings in the field. Covering a wide range of topics, from laboratory research to clinical trials and epidemiologic studies, Cancer Discovery spans the entire spectrum of cancer research and medicine.